Plain-English translation of NCT06493071 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing a treatment called transcutaneous auricular vagus nerve stimulation (taVNS), which uses a small device to deliver gentle electrical stimulation to a specific part of your ear. The goal is to activate your vagus nerve โ a major nerve in your body โ to reduce inflammation and improve depression symptoms in people with spinal cord injury. Researchers believe this simple, non-invasive approach may work where other treatments fall short.
Depression and chronic inflammation are very common after spinal cord injury, and they often go hand in hand. While diet and exercise can help, they're hard to stick with long-term. This treatment was chosen because it's easy to use at home, low-cost, and has shown promise in reducing inflammation and depression in other chronic conditions โ but it hasn't been tested yet in people with spinal cord injury.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will be randomly assigned to receive either real or placebo electrical stimulation on your ear using a small device called NEMOS. Over 30 days, you'll use the device for about 4 hours daily (at least 1 hour in one continuous session). Researchers will measure your depression symptoms and blood markers of inflammation before and after the study to see if the treatment helps. The entire process is non-invasive โ the device simply clips onto your ear and delivers mild electrical stimulation.
AI-generated summary from trial data ยท Jun 20, 2026 ยท Not medical advice
Canada